ISO 27001 Certificate
SOC 1 Type I Certificate
SOC 2 Type II Certificate
PCI DSS
HIPAA
RGPD
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
ISOSOC2 Type 1SOC2 Type 2PCI DSSHIPAAGDPR

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Cipla A.I CyberSecurity Scoring

Cipla

Company Details

Linkedin ID:

cipla

Employees number:

49,702

Number of followers:

1,999,660

NAICS:

3254

Industry Type:

Pharmaceutical Manufacturing

Homepage:

cipla.com

IP Addresses:

0

Company ID:

CIP_8144792

Scan Status:

In-progress

AI scoreCipla Risk Score (AI oriented)

Between 750 and 799

https://images.rankiteo.com/companyimages/cipla.jpeg
Cipla Pharmaceutical Manufacturing
Updated:
  • Powered by our proprietary A.I cyber incident model
  • Insurance preferes TPRM score to calculate premium
globalscoreCipla Global Score (TPRM)

XXXX

https://images.rankiteo.com/companyimages/cipla.jpeg
Cipla Pharmaceutical Manufacturing
  • Instant access to detailed risk factors
  • Benchmark vs. industry & size peers
  • Vulnerabilities
  • Findings

Cipla Company CyberSecurity News & History

Past Incidents
0
Attack Types
0
No data available
Ailogo

Cipla Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

🔒
Incident Predictions locked
Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

🔒
A.I. Risk Score Predictions locked
Access Monitoring Plan
statics

Underwriter Stats for Cipla

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Cipla in 2025.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Cipla in 2025.

Incident Types Cipla vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Cipla in 2025.

Incident History — Cipla (X = Date, Y = Severity)

Cipla cyber incidents detection timeline including parent company and subsidiaries

Cipla Company Subsidiaries

SubsidiaryImage

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Loading...
similarCompanies

Cipla Similar Companies

Sanofi

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing t

Hetero Drugs Ltd

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm

Dr. Reddy's Laboratories

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics

Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t

Parexel

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more th

SUN PHARMA

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread acro

PT Kalbe Farma, Tbk

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t

Fresenius Kabi

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf

Catalent

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier li

newsone

Cipla CyberSecurity News

July 25, 2025 07:00 AM
Cipla gains after Q1 PAT rises 10% YoY to Rs 1,298 crore

Cipla rallied 3.59% to Rs 1540.70 after the company reported 10.18% increase in consolidated net profit to Rs 1297.62 crore on a 3.93% rise...

April 17, 2025 07:00 AM
Infosys to acquire Australian cybersecurity services provider - The Missing Link

Infosys announced a definitive agreement to acquire The Missing Link, an award winning Australian cybersecurity services specialist firm.

December 17, 2024 08:00 AM
This Vijay Kedia portfolio SME stock zoomed 949% over issue price in 9 mths

TAC InfoSec share price hit a new high of Rs 1112.45, locked in an upper circuit for the 9th straight day, and surged 46 per cent during the...

December 11, 2024 08:00 AM
Cipla Reportedly Hacked by Akira Ransomware Group, 70GB of Sensitive Data Allegedly Stolen

Cipla, one of India's leading pharmaceutical companies, has reportedly been targeted by the Akira ransomware group in a cyberattack that allegedly resulted in...

December 09, 2024 08:00 AM
Cipla Allegedly Hacked, Akira Ransomware Claims 70GB Data Stolen

Cipla, the Indian pharmaceutical giant, has reportedly fallen victim to a cyberattack orchestrated by the Akira ransomware group.

June 10, 2024 07:00 AM
Mangesh Vaze joins Zydus Group as President of API Business

Mangesh Vaze has been appointed as the President of API Business of Zydus Group. API stands for application programming interfaces, and Vase has 28 years of...

September 21, 2023 07:00 AM
Cipla's US subsidiary InvaGen gets 5 inspectional observations from USFDA

Cipla announced that the United States Food and Drug Administration (USFDA) had conducted an inspection at its wholly-owned subsidiary, InvaGen Pharmaceuticals.

February 23, 2023 06:03 PM
Samina Hamied

A third-generation heir to Cipla and a fitness enthusiast, Samina Hamied is a marathon runner both in the business world and on the track.

December 20, 2021 08:00 AM
Wipro to acquire cybersecurity provider Edgile for $230 million

Edgile's cybersecurity and risk management professionals are expected to allow Wipro to further enhance its cybersecurity and risk...

faq

Frequently Asked Questions

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.

Cipla CyberSecurity History Information

Official Website of Cipla

The official website of Cipla is http://www.cipla.com.

Cipla’s AI-Generated Cybersecurity Score

According to Rankiteo, Cipla’s AI-generated cybersecurity score is 787, reflecting their Fair security posture.

How many security badges does Cipla’ have ?

According to Rankiteo, Cipla currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Does Cipla have SOC 2 Type 1 certification ?

According to Rankiteo, Cipla is not certified under SOC 2 Type 1.

Does Cipla have SOC 2 Type 2 certification ?

According to Rankiteo, Cipla does not hold a SOC 2 Type 2 certification.

Does Cipla comply with GDPR ?

According to Rankiteo, Cipla is not listed as GDPR compliant.

Does Cipla have PCI DSS certification ?

According to Rankiteo, Cipla does not currently maintain PCI DSS compliance.

Does Cipla comply with HIPAA ?

According to Rankiteo, Cipla is not compliant with HIPAA regulations.

Does Cipla have ISO 27001 certification ?

According to Rankiteo,Cipla is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Industry Classification of Cipla

Cipla operates primarily in the Pharmaceutical Manufacturing industry.

Number of Employees at Cipla

Cipla employs approximately 49,702 people worldwide.

Subsidiaries Owned by Cipla

Cipla presently has no subsidiaries across any sectors.

Cipla’s LinkedIn Followers

Cipla’s official LinkedIn profile has approximately 1,999,660 followers.

NAICS Classification of Cipla

Cipla is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Cipla’s Presence on Crunchbase

No, Cipla does not have a profile on Crunchbase.

Cipla’s Presence on LinkedIn

Yes, Cipla maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/cipla.

Cybersecurity Incidents Involving Cipla

As of December 11, 2025, Rankiteo reports that Cipla has not experienced any cybersecurity incidents.

Number of Peer and Competitor Companies

Cipla has an estimated 5,413 peer or competitor companies worldwide.

Cipla CyberSecurity History Information

How many cyber incidents has Cipla faced ?

Total Incidents: According to Rankiteo, Cipla has faced 0 incidents in the past.

What types of cybersecurity incidents have occurred at Cipla ?

Incident Types: The types of cybersecurity incidents that have occurred include .

Incident Details

What are the most common types of attacks the company has faced ?

Additional Questions

cve

Latest Global CVEs (Not Company-Specific)

Description

FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description

Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.

Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description

The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=cipla' -H 'apikey: YOUR_API_KEY_HERE'

What Do We Measure ?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge